share_log

6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella

6-K: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants and Sanofi in discussions to sell a controlling stake in Opella

6-K:IDWeek上公布的Beyfortus新數據增強預防嬰兒呼吸道合胞病毒疾病和住院治療的實際效果以及賽諾菲安萬特正在討論出售Opella的控股權
美股SEC公告 ·  10/11 12:39
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息